AAAAAA

   
Results: 1-23 |
Results: 23
HEMATOLOGICAL RESPONSE OF PATIENTS WITH MYELODYSPLASTIC SYNDROME TO ANTITHYMOCYTE GLOBULIN IS ASSOCIATED WITH A LOSS OF LYMPHOCYTE-MEDIATEDINHIBITION OF CFU-GM AND ALTERATIONS IN T-CELL RECEPTOR V-BETA PROFILES
Authors: MOLLDREM JJ JIANG YZ STETLERSTEVENSON M MAVROUDIS D HENSEL N BARRETT AJ
Citation: Jj. Molldrem et al., HEMATOLOGICAL RESPONSE OF PATIENTS WITH MYELODYSPLASTIC SYNDROME TO ANTITHYMOCYTE GLOBULIN IS ASSOCIATED WITH A LOSS OF LYMPHOCYTE-MEDIATEDINHIBITION OF CFU-GM AND ALTERATIONS IN T-CELL RECEPTOR V-BETA PROFILES, British Journal of Haematology, 102(5), 1998, pp. 1314-1322
SPECIFIC DEPLETION OF ALLOREACTIVE T-CELLS IN HLA-IDENTICAL SIBLINGS - A METHOD FOR SEPARATING GRAFT-VERSUS-HOST AND GRAFT-VERSUS-LEUKEMIA REACTIONS
Authors: MAVROUDIS DA DERMIME S MOLLDREM J JIANG YZ RAPTIS A VANRHEE F HENSEL N FELLOWES V ELIOPOULOS G BARRETT AJ
Citation: Da. Mavroudis et al., SPECIFIC DEPLETION OF ALLOREACTIVE T-CELLS IN HLA-IDENTICAL SIBLINGS - A METHOD FOR SEPARATING GRAFT-VERSUS-HOST AND GRAFT-VERSUS-LEUKEMIA REACTIONS, British Journal of Haematology, 101(3), 1998, pp. 565-570
IMMUNE ESCAPE FROM A GRAFT-VERSUS-LEUKEMIA EFFECT MAY PLAY A ROLE IN THE RELAPSE OF MYELOID LEUKEMIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: DERMIME S MAVROUDIS D JIANG YZ HENSEL N MOLLDREM J BARRETT AJ
Citation: S. Dermime et al., IMMUNE ESCAPE FROM A GRAFT-VERSUS-LEUKEMIA EFFECT MAY PLAY A ROLE IN THE RELAPSE OF MYELOID LEUKEMIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(10), 1997, pp. 989-999
CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR A NONPOLYMORPHIC PROTEINASE-3 PEPTIDE PREFERENTIALLY INHIBIT CHRONIC MYELOID-LEUKEMIA COLONY-FORMING-UNITS
Authors: MOLLDREM JJ CLAVE E JIANG YZ MAVROUDIS D RAPTIS A HENSEL N AGARWALA V BARRETT AJ
Citation: Jj. Molldrem et al., CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR A NONPOLYMORPHIC PROTEINASE-3 PEPTIDE PREFERENTIALLY INHIBIT CHRONIC MYELOID-LEUKEMIA COLONY-FORMING-UNITS, Blood, 90(7), 1997, pp. 2529-2534
HIGH-DOSE METHYLPREDNISOLONE IMPROVES OUTCOME OF DIFFUSE ALVEOLAR HEMORRHAGE (DAH) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) FOR HEMATOLOGICAL MALIGNANCIES
Authors: RAPTIS A MAVROUDIS D MOLLDREM J CHILDS R LEDAKIS P BAHCECI E VANRHEE F HENSEL N PHANG S BARRETT AJ
Citation: A. Raptis et al., HIGH-DOSE METHYLPREDNISOLONE IMPROVES OUTCOME OF DIFFUSE ALVEOLAR HEMORRHAGE (DAH) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) FOR HEMATOLOGICAL MALIGNANCIES, Blood, 90(10), 1997, pp. 4382-4382
HEMATOLOGICAL RESPONSE OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) TO ANTITHYMOCYTE GLOBULIN (ATG) TREATMENT IS ASSOCIATED WITH A LOSS OF CD8-CELL MEDIATED CFU-GM INHIBITION( T)
Authors: MOLLDREM JJ JIANG YZ MAVROUDIS D RAPTIS A HENSEL N BARRETT AJ
Citation: Jj. Molldrem et al., HEMATOLOGICAL RESPONSE OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) TO ANTITHYMOCYTE GLOBULIN (ATG) TREATMENT IS ASSOCIATED WITH A LOSS OF CD8-CELL MEDIATED CFU-GM INHIBITION( T), Blood, 90(10), 1997, pp. 369-369
GRANULOCYTE-COLONY-STIMULATING-FACTOR (G-CSF) MOBILIZED CD34-CELLS( CELLS PROCESS AND PRESENT EXOGENOUS ANTIGEN TO T)
Authors: VANRHEE F JIANG YZ VIGUE F KIRBY M RAPTIS A HENSEL N AGARWALA V READ EJ BARRETT AJ
Citation: F. Vanrhee et al., GRANULOCYTE-COLONY-STIMULATING-FACTOR (G-CSF) MOBILIZED CD34-CELLS( CELLS PROCESS AND PRESENT EXOGENOUS ANTIGEN TO T), Blood, 90(10), 1997, pp. 1614-1614
BONE-MARROW AND BLOOD SHOW CONSISTENT DIFFERENCES IN THE T-CELL RECEPTOR (TCR) V-BETA REPERTOIRE
Authors: JIANG YZ CLAVE E MOLLDREM J RAPTIS A VANRHEE F MAVROUDIS D HENSEL N BARRETT AJ
Citation: Yz. Jiang et al., BONE-MARROW AND BLOOD SHOW CONSISTENT DIFFERENCES IN THE T-CELL RECEPTOR (TCR) V-BETA REPERTOIRE, Blood, 90(10), 1997, pp. 2014-2014
CYTOTOXIC T-CELL LINES (CTL) SPECIFIC FOR A PROTEINASE-3 (P3) - DERIVED PEPTIDE LYSE A P3-TRANSFECTED B-CELL LINE AND INHIBIT GROWTH OF CLONOGENIC CHRONIC MYELOID-LEUKEMIA (CML) CELLS
Authors: MOLLDREM JJ CLAVE E RAPTIS A HENSEL N BARRETT AJ
Citation: Jj. Molldrem et al., CYTOTOXIC T-CELL LINES (CTL) SPECIFIC FOR A PROTEINASE-3 (P3) - DERIVED PEPTIDE LYSE A P3-TRANSFECTED B-CELL LINE AND INHIBIT GROWTH OF CLONOGENIC CHRONIC MYELOID-LEUKEMIA (CML) CELLS, Blood, 90(10), 1997, pp. 2242-2242
DONOR-RECIPIENT POLYMORPHISM OF THE PROTEINASE-3 GENE IN BONE-MARROW TRANSPLANTATION
Authors: CLAVE E MOLLDREM J HENSEL N RAPTIS A BARRETT AJ
Citation: E. Clave et al., DONOR-RECIPIENT POLYMORPHISM OF THE PROTEINASE-3 GENE IN BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 2379-2379
POLYMORPHISM OF THE LEUKOCYTE DIFFERENTIATION ANTIGEN CD33 - A MYELOID-RESTRICTED MINOR ANTIGEN
Authors: RAPTIS A CLAVE E MAVROUDIS D VANRHEE F HENSEL N LEDAKIS P MOLLDREM J BARRETT AJ
Citation: A. Raptis et al., POLYMORPHISM OF THE LEUKOCYTE DIFFERENTIATION ANTIGEN CD33 - A MYELOID-RESTRICTED MINOR ANTIGEN, Blood, 90(10), 1997, pp. 2386-2386
SPECIFIC DEPLETION OF ALLOREACTIVITY AGAINST HAPLOTYPE MISMATCHED RELATED INDIVIDUALS BY A RECOMBINANT IMMUNOTOXIN - A NEW APPROACH TO GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION
Authors: MAVROUDIS DA JIANG YZ HENSEL N LEWALLE P COURIEL D KREITMAN RJ PASTAN I BARRETT AJ
Citation: Da. Mavroudis et al., SPECIFIC DEPLETION OF ALLOREACTIVITY AGAINST HAPLOTYPE MISMATCHED RELATED INDIVIDUALS BY A RECOMBINANT IMMUNOTOXIN - A NEW APPROACH TO GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 17(5), 1996, pp. 793-799
ALLOREACTIVE CD4(-LYMPHOCYTES CAN EXERT CYTOTOXICITY TO CHRONIC MYELOID-LEUKEMIA CELLS PROCESSING AND PRESENTING EXOGENOUS ANTIGEN() T)
Authors: JIANG YZ MAVROUDIS D DERMIME S HENSEL N COURIEL D MOLLDREM J BARRETT AJ
Citation: Yz. Jiang et al., ALLOREACTIVE CD4(-LYMPHOCYTES CAN EXERT CYTOTOXICITY TO CHRONIC MYELOID-LEUKEMIA CELLS PROCESSING AND PRESENTING EXOGENOUS ANTIGEN() T), British Journal of Haematology, 93(3), 1996, pp. 606-612
HELPER AND CYTOTOXIC LYMPHOCYTE-RESPONSES TO CHRONIC MYELOID-LEUKEMIA- IMPLICATIONS FOR ADOPTIVE IMMUNOTHERAPY WITH T-CELLS
Authors: LEWALLE P HENSEL N GUIMARAES A COURIEL D JIANG YZ MAVROUDIS D BARRETT AJ
Citation: P. Lewalle et al., HELPER AND CYTOTOXIC LYMPHOCYTE-RESPONSES TO CHRONIC MYELOID-LEUKEMIA- IMPLICATIONS FOR ADOPTIVE IMMUNOTHERAPY WITH T-CELLS, British Journal of Haematology, 92(3), 1996, pp. 587-594
TARGETED T-CELL THERAPY FOR HUMAN LEUKEMIA - CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR A PEPTIDE DERIVED FROM PROTEINASE-3 PREFERENTIALLY LYSE HUMAN MYELOID-LEUKEMIA CELLS
Authors: MOLLDREM J DERMIME S PARKER K JIANG YZ MAVROUDIS D HENSEL N FUKUSHIMA P BARRETT AJ
Citation: J. Molldrem et al., TARGETED T-CELL THERAPY FOR HUMAN LEUKEMIA - CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR A PEPTIDE DERIVED FROM PROTEINASE-3 PREFERENTIALLY LYSE HUMAN MYELOID-LEUKEMIA CELLS, Blood, 88(7), 1996, pp. 2450-2457
LIMITED USE OF T-CELL RECEPTOR (TCR) V-BETA BY ALLOGENEIC T-CELLS RESPONDING TO CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPLICATIONS FOR SPECIFICALLY ENHANCING THE GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT
Authors: JIANG YZ MAYROUDIS DA DERMINE S MOLLDREM J HENSEL N BARRETT AJ
Citation: Yz. Jiang et al., LIMITED USE OF T-CELL RECEPTOR (TCR) V-BETA BY ALLOGENEIC T-CELLS RESPONDING TO CHRONIC MYELOGENOUS LEUKEMIA (CML) - IMPLICATIONS FOR SPECIFICALLY ENHANCING THE GRAFT-VERSUS-LEUKEMIA (GVL) EFFECT, Blood, 88(10), 1996, pp. 962-962
SELECTIVE IMMUNODEPLETION BETWEEN HLA MATCHED SIBLINGS THAT REDUCES THE RISK FOR GVHD AND PRESERVES REACTIVITY AGAINST THE LEUKEMIA AND EPSTEIN-BARR-VIRUS
Authors: MAYROUDIS D DERMIME S JIANG YZ MOLLDREM J HENSEL N FELLOWES Y RAPTIS A BARRETT AJ
Citation: D. Mayroudis et al., SELECTIVE IMMUNODEPLETION BETWEEN HLA MATCHED SIBLINGS THAT REDUCES THE RISK FOR GVHD AND PRESERVES REACTIVITY AGAINST THE LEUKEMIA AND EPSTEIN-BARR-VIRUS, Blood, 88(10), 1996, pp. 1005-1005
IMMUNE ESCAPE FROM A GRAFT-VERSUS-LEUKEMIA EFFECT PLAY A ROLE IN THE RELAPSE OF MYELOGENOUS LEUKEMIAS FOLLOWING ALLOGENEIC DONE MARROW TRANSPLANTATION
Authors: DERMIME S MAVROUDIS D JIANG YZ HENSEL N MOLLDREM J BARRETT AJ
Citation: S. Dermime et al., IMMUNE ESCAPE FROM A GRAFT-VERSUS-LEUKEMIA EFFECT PLAY A ROLE IN THE RELAPSE OF MYELOGENOUS LEUKEMIAS FOLLOWING ALLOGENEIC DONE MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 2430-2430
HUMAN CD8(-LYMPHOCYTES RECOGNIZE THE FUSION REGION OF BCR() T)ABL HYBRID PROTEIN PRESENT IN CHRONIC MYELOGENOUS LEUKEMIA/
Authors: DERMIME S MOLLDREM J PARKER KC JIANG YZ MAVROUDIS D HENSEL N COURIEL D MAHONEY M COLIGAN JE BARRETT AJ
Citation: S. Dermime et al., HUMAN CD8(-LYMPHOCYTES RECOGNIZE THE FUSION REGION OF BCR() T)ABL HYBRID PROTEIN PRESENT IN CHRONIC MYELOGENOUS LEUKEMIA/, Blood, 86(10), 1995, pp. 620-620
DONOR-VERSUS-RECIPIENT HELPER T-LYMPHOCYTE PRECURSOR NUMBERS GIVEN BUT NOT THEIR FREQUENCY PREDICTS GVHD IN HLA MATCHED SIBLING BMT
Authors: COURIEL D MAHONEY M HENSEL N MAVROUDIS D JIANG YZ DERMIME S MOLLDREM J BARRETT AJ
Citation: D. Couriel et al., DONOR-VERSUS-RECIPIENT HELPER T-LYMPHOCYTE PRECURSOR NUMBERS GIVEN BUT NOT THEIR FREQUENCY PREDICTS GVHD IN HLA MATCHED SIBLING BMT, Blood, 86(10), 1995, pp. 1575-1575
CYTOTOXIC T-CELLS SHOW SPECIFICITY TO MHC CLASS I-RESTRICTED PEPTIDE DERIVED FROM PROTEINASE-3, A LEUKEMIA-ASSOCIATED PROTEIN
Authors: MOLLDREM J DERMIME S PARKER K COURIEL D HENSEL N JIANG YZ MAVROUDIS D MAHONEY M BARRETT J
Citation: J. Molldrem et al., CYTOTOXIC T-CELLS SHOW SPECIFICITY TO MHC CLASS I-RESTRICTED PEPTIDE DERIVED FROM PROTEINASE-3, A LEUKEMIA-ASSOCIATED PROTEIN, Blood, 86(10), 1995, pp. 1695-1695
SPECIFIC DEPLETION OF DONOR-VERSUS-RECIPIENT ALLOREACTIVITY TO PREVENT GVHD AFTER MARROW TRANSPLANTATION
Authors: MAYROUDIS D JIANG YZ HENSEL N COURIEL D DERMIME S MAHONEY M BARRETT AJ
Citation: D. Mayroudis et al., SPECIFIC DEPLETION OF DONOR-VERSUS-RECIPIENT ALLOREACTIVITY TO PREVENT GVHD AFTER MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2267-2267
T-CELL DEPLETED MARROW TRANSPLANTS WITH DELAYED LYMPHOCYTE ADD-BACK TO PREVENT RELAPSE IN PATIENTS WITH LEUKEMIA AND MDS
Authors: COURIEL D COTTLERFOX M BURT RK DUNBAR C HENSEL N YOUNG NS BARRETT AJ
Citation: D. Couriel et al., T-CELL DEPLETED MARROW TRANSPLANTS WITH DELAYED LYMPHOCYTE ADD-BACK TO PREVENT RELAPSE IN PATIENTS WITH LEUKEMIA AND MDS, Blood, 84(10), 1994, pp. 10000334-10000334
Risultati: 1-23 |